ArticleBMC cancer2021

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.

Sebastian Krug et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.